Published in Psychoneuroendocrinology on February 19, 2010
Dendritic spine pathology in schizophrenia. Neuroscience (2012) 1.91
Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions. Eur J Neurosci (2012) 1.04
Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Mol Psychiatry (2015) 0.92
Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia. Neuropsychopharmacology (2015) 0.92
The role of estrogen in the treatment of men with schizophrenia. Int J Endocrinol Metab (2013) 0.83
The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia. Schizophr Res Treatment (2012) 0.80
Aging and substitutive hormonal therapy influence in regional and subcellular distribution of ERα in female rat brain. Age (Dordr) (2012) 0.78
Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia. CNS Drugs (2016) 0.78
Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial. Daru (2014) 0.77
Neuroimmunological aberrations and cerebral asymmetry abnormalities in schizophrenia: select perspectives on pathogenesis. Clin Psychopharmacol Neurosci (2014) 0.77
Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia. Transl Psychiatry (2016) 0.76
Successful use of adjuvant raloxifene treatment in clozapine-resistant schizophrenia. Indian J Psychiatry (2012) 0.76
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial. Schizophr Bull (2015) 0.76
A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings. Int J Endocrinol (2015) 0.76
DNA methylation patterns of protein-coding genes and long non-coding RNAs in males with schizophrenia. Mol Med Rep (2015) 0.75
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry (2007) 5.59
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Urinary incontinence in young nulligravid women: a cross-sectional analysis. Ann Intern Med (2012) 3.34
The elephant on the couch: side-effects of psychotherapy. Aust N Z J Psychiatry (2009) 3.31
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry (2010) 2.99
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol (2008) 2.44
A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry (2011) 2.44
Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab (2010) 2.27
Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem (2009) 2.13
Incidence of total knee and hip replacement for osteoarthritis in relation to circulating sex steroid hormone concentrations in women. Arthritis Rheumatol (2014) 2.05
A prospective study of the relationship between sense of coherence, depression, anxiety, and quality of life of haematopoietic stem cell transplant patients over time. Psychooncology (2014) 2.05
The role of alprazolam for the treatment of panic disorder in Australia. Aust N Z J Psychiatry (2012) 2.02
Group-based psychosocial intervention for bipolar disorder: randomised controlled trial. Br J Psychiatry (2010) 2.02
Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry (2009) 2.01
Women survivors of child abuse - don't ask, don't tell. Aust Fam Physician (2012) 2.01
A survey of combination antidepressant use in Australia. Australas Psychiatry (2007) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.97
The mechanisms of interhemispheric inhibition in the human motor cortex. J Physiol (2002) 1.92
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Sexual function after breast cancer. J Sex Med (2010) 1.89
The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology (2008) 1.88
Maternal and early postnatal nutrition and mental health of offspring by age 5 years: a prospective cohort study. J Am Acad Child Adolesc Psychiatry (2013) 1.87
Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry (2008) 1.78
Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry (2011) 1.77
The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta (2013) 1.72
Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause (2015) 1.71
Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause (2007) 1.70
Moving towards a population health approach to the primary prevention of common mental disorders. BMC Med (2012) 1.65
Hormone replacement therapy: current controversies. Clin Endocrinol (Oxf) (2003) 1.64
The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J Clin Psychiatry (2010) 1.64
Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause (2003) 1.62
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology (2007) 1.61
Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol (2004) 1.60
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
Abnormalities in osteoclastogenesis and decreased tumorigenesis in mice deficient for ovarian cancer G protein-coupled receptor 1. PLoS One (2009) 1.55
N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther (2008) 1.54
Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Lipid Res (2010) 1.53
The cross-sectional relationship between fortnightly exercise and knee cartilage properties in healthy adult women in midlife. Menopause (2007) 1.53
The association between habitual diet quality and the common mental disorders in community-dwelling adults: the Hordaland Health study. Psychosom Med (2011) 1.52
Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry (2010) 1.51
Oxidative pathways as a drug target for the treatment of autism. Expert Opin Ther Targets (2010) 1.51
Improving working memory: the effect of combining cognitive activity and anodal transcranial direct current stimulation to the left dorsolateral prefrontal cortex. Brain Stimul (2010) 1.50
Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev (2010) 1.49
Psychological needs of adolescents in the early phase of bipolar disorder: implications for early intervention. Early Interv Psychiatry (2011) 1.46
Diagnosis of myalgic encephalomyelitis: where are we now? Expert Opin Med Diagn (2013) 1.43
N-acetylcysteine for major depressive episodes in bipolar disorder. Rev Bras Psiquiatr (2011) 1.43
Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry (2013) 1.43
Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis. Menopause (2013) 1.41
Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry (2007) 1.41
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry (2002) 1.39
Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski-/- mice. Nat Genet (2001) 1.39
Bipolar disorder: new understandings, emerging treatments. Med J Aust (2010) 1.38
Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women. Menopause (2016) 1.38
Depolarizing bipolar disorder: both the illness and our views. Aust N Z J Psychiatry (2011) 1.38
A prospective study of diet quality and mental health in adolescents. PLoS One (2011) 1.38
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med (2012) 1.37
A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology (2005) 1.36
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci (2011) 1.35
Treatment of menopausal symptoms: what shall we do now? Lancet (2005) 1.35
Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry (2010) 1.35
Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry (2008) 1.33
KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis (2005) 1.33
Associations between diet quality and depressed mood in adolescents: results from the Australian Healthy Neighbourhoods Study. Aust N Z J Psychiatry (2010) 1.31
Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry (2008) 1.31
Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J Clin Oncol (2007) 1.30
Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30
Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res (2006) 1.29
Testing the limits: Investigating the effect of tDCS dose on working memory enhancement in healthy controls. Neuropsychologia (2013) 1.29
The use of tDCS and CVS as methods of non-invasive brain stimulation. Brain Res Rev (2007) 1.28
New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab (2003) 1.27
Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother (2009) 1.26
Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb Cortex (2007) 1.24
A review of the role of female gender in autism spectrum disorders. J Autism Dev Disord (2013) 1.24
Is lithium in a class of its own? A brief profile of its clinical use. Aust N Z J Psychiatry (2009) 1.23
Biomarkers and clinical staging in psychiatry. World Psychiatry (2014) 1.22
Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci (2008) 1.21
The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. J Eval Clin Pract (2008) 1.20
Superior temporal gyrus volume change in schizophrenia: a review on region of interest volumetric studies. Brain Res Rev (2009) 1.20
Is diagnosis enough to guide interventions in mental health? Using case formulation in clinical practice. BMC Med (2012) 1.19
Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord (2012) 1.18
Improving working memory: exploring the effect of transcranial random noise stimulation and transcranial direct current stimulation on the dorsolateral prefrontal cortex. Clin Neurophysiol (2011) 1.17
Antidepressants and the placebo response. Hum Psychopharmacol (2005) 1.17
The association between diet quality, dietary patterns and depression in adults: a systematic review. BMC Psychiatry (2013) 1.16
Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. BMC Med (2012) 1.16
Traumatic brain injury, major depression, and diffusion tensor imaging: making connections. Brain Res Rev (2010) 1.15
The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res (2006) 1.15
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. Lab Invest (2012) 1.15
Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation. Hum Brain Mapp (2010) 1.14
The effect of macroeconomic variables on suicide. Psychol Med (2005) 1.14
Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Ann Acad Med Singapore (2009) 1.14
Investigating the cortical origins of motor overflow. Brain Res Brain Res Rev (2004) 1.14